Tag: BioTime

November 5, 2018

8 Anti-aging Company Stocks

It can be tough to find public anti-aging companies to invest in, but it's certainly possible with a little time...
August 2, 2018

BioTime to Receive $43 Million From Juvenescence

BioTime (NYSE:BTX), a clinical-stage biotechnology company focused on degenerative diseases, announced a new strategic alignment between AgeX Therapeutics and Juvenescence...
October 20, 2016

BioTime to Present OpRegen® Clinical Trial Data at ISOPT Clinical Symposium

BioTime, a clinical stage biotechnology company with a focus on pluripotent stem cell technologies, today reported that data from the...
June 16, 2016

BioTime, Inc. Announces Pricing of Public Offering of Common Stock

ALAMEDA, Calif.–(BUSINESS WIRE)–BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company focused on developing and commercializing novel therapies in the...
June 10, 2016

BioTime Announces $2.2 Million Grant for Further Development of Dry-AMD Program

ALAMEDA, Calif. & JERUSALEM–(BUSINESS WIRE)–BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage regenerative medicine company with a focus on...
February 17, 2016

Asterias Biotherapeutics Announces Intention to Distribute 3.15 Million Warrants

Asterias Biotherapeutics, Inc. (NYSEMKT:AST) simplified its capital structure through the previously announced Asset Swap with BioTime, Inc. In conjunction with...
December 30, 2015

Stock of BioTime Subsidiary to Begin Trading on the NYSE MKT

BioTime, Inc. (NYSE MKT:BTX) has reported that the common stock of subsidiary OncoCyte Corporation will start trading on a "when-issued"...